Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.23.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Oct. 31, 2023
Oct. 31, 2022
Current assets:    
Cash and cash equivalents $ 915 $ 12,360
Short–term investments 22,929 17,327
Receivables 270 46
Prepaid expenses and other current assets 1,242 467
Total current assets 25,356 30,200
Operating lease right-of-use asset 166 212
Total assets 25,522 30,412
Current liabilities:    
Accounts payable 206 265
Accrued expenses 1,770 1,726
Operating lease liability 52 46
Total current liabilities 2,028 2,037
Operating lease liability, non-current 123 175
Total liabilities 2,151 2,212
Equity:    
Preferred stock, value
Common stock, par value $.01 per share; 100,000,000 shares authorized; 31,145,219 and 30,913,902 shares issued and outstanding as of October 31, 2023 and 2022, respectively 311 309
Additional paid-in capital 252,222 247,123
Accumulated deficit (228,196) (218,385)
Total shareholders’ equity 24,337 29,047
Noncontrolling interest (Note 2) (966) (847)
Total equity 23,371 28,200
Total liabilities and equity 25,522 30,412
Series A Convertible Preferred Stock [Member]    
Equity:    
Preferred stock, value